Online Education | Adult/Geriatric Drug Therapy 2016 - Risks and Benefits of PSA Screening for Prostate Cancer

Graphic for Adult/Geriatric Drug Therapy course at UWCNE.
Risks and Benefits of PSA Screening for Prostate Cancer

Course Description

This module is designed as an update on practice changes in the management of localized prostate cancer and the potential impact on the harms and benefits of PSA screening.

Featuring—

John L. Gore, MD, MS

Associate Professor, Urology, University of Washington Medical Center, Seattle

Comments from lecture attendees:

"Fantastic. Dr. Gore’s review of recent PSA confusing guidelines was very, very helpful. I will share this information."

"The PSA lecture was one of the best that I have attended."

 

Target Audience

For adult nurse practitioners, geriatric nurse practitioners, family nurse practitioners, clinical nurse specialists, nurses, pharmacists and other interested healthcare professionals. 

Objectives for Learning Outcomes

After taking this module, you will be better able to:

1. Recognize the harms associated with PSA screening.

2. Discuss the limitations of US and European screening trials.

3. Describe populations that may benefit from PSA screening.

 

Additional Information

Format: 
Audio and Video
Course summary
Maximum credit available: 
  • 1.10 Contact hours
  • 1.10 Pharmacology hours at the advanced practice level
Available: 
08/11/2016
Expires: 
08/11/2020
Cost:
$20.00

Available Credit

  • 1.10 Contact hours
  • 1.10 Pharmacology hours at the advanced practice level

Price

Cost:
$20.00
Please login or create account to take this course.

Required Hardware/software

Adobe Acrobat Reader
Google Chrome, Firefox or Safari